PS
EBS icon

Principal Securities’s Emergent Biosolutions EBS Stock Holding History

Principal Securities’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-176
Closed -$1.55K – 1931
2025
Q3 		$1.55K Hold
176
– – ﹤0.01% 3290
2025
Q2 		$1.12K Buy
176
+76
+76% +$435 ﹤0.01% 3309
2025
Q1 		$956 Hold
100
– – ﹤0.01% 3223
2024
Q4 		$956 Hold
100
– – ﹤0.01% 3216
2024
Q3 		$835 Buy
+100
New +$909 ﹤0.01% 3174

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OHA
Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $2.3B AUM 29.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Principal Securities's EBS Position: Q4 2025 in Review

Principal Securities sold out of Emergent Biosolutions (EBS) in Q4 2025, closing a stake of 176 shares — an estimated $1.55K sold.

Principal Securities first reported a position in EBS in Q3 2024 and held it in 5 quarters. The position peaked at $1.55K in Q3 2025. 183 funds tracked by Wall St. Rank hold EBS as of Q4 2025.

  • Principal Securities reported no remaining Emergent Biosolutions position as of Q4 2025 after selling out during the quarter.
  • Principal Securities sold 176 Emergent Biosolutions shares in Q4 2025, an estimated $1.55K.
  • Principal Securities first reported a position in Emergent Biosolutions in Q3 2024 and held it in 5 quarters.
  • Principal Securities's Emergent Biosolutions position peaked at $1.55K in Q3 2025.
  • 183 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2025.

Based on Principal Securities's 13F filing for Q4 2025, filed 12 Feb 2026.